| Literature DB >> 17640384 |
Stéphane Hugonnet1, Ilker Uçkay, Didier Pittet.
Abstract
INTRODUCTION: The clinical and economic burden of ventilator-associated pneumonia (VAP) is uncontested. We conducted the present study to determine whether low nurse-to-patient ratio increases the risk for VAP and whether this effect is similar for early-onset and late-onset VAP.Entities:
Mesh:
Year: 2007 PMID: 17640384 PMCID: PMC2206525 DOI: 10.1186/cc5974
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Characteristics of the study population
| Characteristic | Total population | Patients with VAP | Patients without VAP |
| Number of patients | 936 | 209 | 727 |
| Age (years) | 65 (50 to 75) | 64 (54 to 74) | 65 (48 to 75) |
| Male sex | 552 (59.0) | 125 (59.8) | 427 (58.7) |
| Charlson score at admissiona | |||
| 0 | 335 (35.8) | 69 (33.0) | 266 (36.6) |
| 1 to 2 | 326 (34.8) | 91 (43.5) | 235 (32.3) |
| 3 to 5 | 184 (19.7) | 34 (16.3) | 150 (20.6) |
| > 5 | 91 (9.7) | 15 (7.2) | 76 (10.5) |
| APACHE II score at admissionb | |||
| < 26 | 367 (40.3) | 74 (37.2) | 293 (41.2) |
| 26 to 30 | 170 (18.7) | 37 (18.6) | 133 (18.7) |
| > 30 | 373 (41.0) | 88 (44.2) | 285 (40.1) |
| Nursing acuity score at admission | 226 (199 to 226) | 226 (200 to 226) | 226 (196 to 226) |
| Admission diagnosis | |||
| Infectious diseasea | 238 (25.4) | 70 (33.5) | 168 (23.1) |
| Cardiovascular condition | 315 (33.7) | 76 (36.4) | 239 (32.9) |
| Pulmonary disease | 139 (14.9) | 27 (12.9) | 112 (15.4) |
| Othera | 244 (26.1) | 36 (17.2) | 208 (28.6) |
| ICU stay (days)a | 6 (3 to 11) | 15 (10 to 23) | 5 (3 to 8) |
| Duration of mechanical ventilation (days)a | 3 (2 to 8) | 11 (6 to 19) | 3 (2 to 6) |
| ICU mortality | 297 (31.7) | 70 (33.5) | 227 (31.2) |
| Hospital stay (days)a | 18 (7 to 38) | 29 (17 to 67) | 14 (5 to 32) |
| Hospital mortality | 381 (40.7) | 94 (45.0) | 287 (39.5) |
Values are expressed as numbers (%) or median (interquartile range) for continuous variables. aSignificant difference between patients with and without VAP (P < 0.05). bTwenty-six missing values. APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; VAP, ventilator-associated pneumonia.
Distribution of leading pathogens in patients with ventilator-associated pneumonia
| Details regarding episodes of infection | Total (%)a |
| Number of episodes microbiologically documented | 177 |
| Number of microorganisms identified | 271 |
| Gram-negative microorganisms | 140 (52) |
| | 25 (9) |
| | 20 (7) |
| | 17 (6) |
| | 15 (6) |
| | 7 (3) |
| | 6 (2) |
| Non-aeruginosa | 6 (2) |
| | 5 (2) |
| Other Gram-negative micro-organismsb | 39 (14) |
| Gram-positive microorganisms | 75 (28) |
| | 55 (20) |
| Coagulase-negative staphylococci | 10 (4) |
| | 3 (1) |
| | 2 (1) |
| Other streptococci | 2 (1) |
| Other Gram-positive micro-organisms | 3 (1) |
| Other micro-organisms | 56 (21) |
| 34 (13) | |
| Non-albicans | 6 (2) |
| Other micro-organismsc | 16 (6) |
aThe percentage given is that of the total number of micro-organisms (n = 271). bOther Gram-negative microorgamisms included other enterobacteriaceae, Acinetobacter spp., Citrobacter spp., other Klebsiella spp. and Morganella morgani. cOther micro-organisms include fungi and viruses.
Risk factors for ventilator-associated pneumonia: crude and adjusted effect of staffing level
| Risk factor | Early-onset VAP | Late-onset VAP | ||
| Crude HR (95% CI) | Adjusted HR (95% CI) | Crude HR (95% CI) | Adjusted HR (95% CI) | |
| Nurse-to-patient ratio | 0.77 (0.42 to 1.40) | 0.78 (0.42 to 1.45) | 0.43 (0.18 to 1.02) | 0.42 (0.18 to 0.99) |
| Patient age | 1.00 (0.99 to 1.01) | - | 1.00 (0.99 to 1.01) | - |
| Male gender | 0.92 (0.62 to 1.38) | - | 1.15 (0.79 to 1.69) | - |
| Nursing acuity severity score | 0.96 (0.92 to 1.01) | - | 1.03 (1.00 to 1.07) | 1.04 (1.00 to 1.08) |
| Charlson score | 0.89 (0.81 to 0.99) | 0.89 (0.80 to 0.98) | 0.96 (0.87 to 1.05) | |
| Admission diagnosis | ||||
| Infectious disease | 0.75 (0.46 to 1.20) | - | 1.09 (0.75 to 1.60) | - |
| Cardiovascular condition | 1.63 (1.10 to 2.41) | - | 1.47 (0.97 to 2.23) | - |
| Pulmonary disease | 0.77 (0.44 to 1.33) | - | 0.56 (0.31 to 1.02) | 0.53 (0.29 to 0.97) |
| Other | 0.87 (0.53 to 1.41) | - | 0.84 (0.49 to 1.43) | - |
| APACHE II score | ||||
| < 26 | 1 | - | 1 | - |
| 26 to 30 | 1.12 (0.67 to 1.86) | - | 0.92 (0.49 to 1.72) | - |
| > 30 | 0.83 (0.53 to 1.31) | - | 1.08 (0.70 to 1.67) | - |
| Nursing training levela | 0.84 (0.60 to 1.18) | - | 1.19 (0.91 to 1.56) | - |
| Invasive devices | ||||
| Central vascular line | 1.50 (0.92 to 2.45) | 1.71 (1.05 to 2.81) | 3.06 (0.97 to 9.70) | 4.14 (1.26 to 13.55) |
| Peripheral venous line | 2.06 (0.76 to 5.61) | - | 1.47 (0.95 to 2.29) | 1.65 (1.06 to 2.59) |
| Peripheral arterial line | 0.58 (0.32 to 1.06) | - | 5.65 (0.78 to 40.84) | - |
| Urinary catheter | 1.86 (0.66 to 5.26) | - | 1.31 (0.41 to 4.16) | - |
| Nasogastric tube | 1.40 (0.75 to 2.63) | - | 2.39 (0.76 to 7.54) | - |
| Medication | ||||
| Parenteral nutrition | 0.83 (0.49 to 1.41) | - | 0.99 (0.65 to 1.51) | - |
| Therapeutic antibiotic | 0.48 (0.32 to 0.73) | 0.47 (0.31 to 0.71) | 0.51 (0.29 to 0.91) | 0.34 (0.19 to 0.62) |
| Prophylactic antibiotic | 0.58 (0.18 to 1.84) | - | 1.22 (0.56 to 2.63) | - |
| Gastric antacid drug | 1.34 (0.90 to 2.00) | - | 0.98 (0.66 to 1.46) | - |
aNursing training level is the number of intensive care unit certified nurses divided by the number of trainee nurses in critical care. APACHE, Acute Physiology and Chronic Health Evaluation; CI, confidence intervals; HR, hazard ratio; VAP, ventilator-associated pneumonia.